Aquestive Therapeutics (AQST) Other Non Operating Income (2019 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Other Non Operating Income of -$1.0 million for Q4 2023, down 191.5% quarter-over-quarter from -$353000.0 in Q1 2023.
Aquestive Therapeutics (AQST) Other Non Operating Income (2019 - 2026) Analysis & Trends
Aquestive Therapeutics' Other Non Operating Income history runs 3 years deep, the most recent figure standing at -$1.0 million for Q4 2023.
- In Q4 2023, Other Non Operating Income changed N/A year-over-year to -$1.0 million; the TTM figure through Sep 2024 stood at -$1.0 million (down 191.5% YoY), while the FY2023 annual figure was -$1.4 million, changed N/A from the prior year.
- Other Non Operating Income for Q4 2023 stood at -$1.0 million, down from -$353000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $13.8 million in Q4 2021, with the low at -$4.9 million in Q3 2019.
- The 3-year median for Other Non Operating Income is -$691000.0 (2023), against an average of $1.9 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Aquestive Therapeutics | 554.35 Mn | 554.35 Mn | 9.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.68 Mn |
| Dec 31, 2023 | -1.03 Mn |
| Mar 31, 2023 | -353,000.00 |
| Dec 31, 2021 | 13.82 Mn |
| Sep 30, 2019 | -4.90 Mn |